Category: St. Jude Medical
The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.
A federal judge agrees to toss a lawsuit filed against Johnson & Johnson's Biosense Webster by a former sales rep and her new employer, St. Jude Medical.
St. Jude Medical says the FDA cleared a 2009 warning letter issued over a plant in Plano, Texas, that makes neuromodulation devices.
Here's a look at some of the top regulatory stories for medical device companies this week: Valeant's hostile takeover hopes fade as Allergan war continues; Medtronic hires ex-Senators to lobby for Covidien deal; FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; St. Jude closes $200M NeuroTherm buy; Medtronic-Covidien merger means tax hit for all stockholders, including execs
Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific reveals federal probe of BridgePoint buy, sales; Court defines 'breast implant' in Dow Corning's $2B product liability saga; Apex fights to get respiratory masks back in Germany; St. Jude and Volcano call a cease-fire
St. Jude Medical and Volcano agree to settle all litigation between them, putting to bed years of lawsuits over medical lasers and fractional flow reserve devices.
St. Jude Medical puts a ribbon on its $200 million cash acquisition of radiofrequency ablation devices maker NeuroTherm.
Medtech titan St. Jude Medical (NYSE:STJ) officially entered the spinal pain market this week, announcing the close of its $200 million cash acquisition of NeuroTherm.